| Identification | Back Directory | [Name]
6H-Pyrrolo[2,3-d]pyrimidin-6-one, 4-amino-2-[5-fluoro-1-[(2-fluorophenyl)methyl]-6-methyl-1H-pyrazolo[3,4-b]pyridin-3-yl]-5,7-dihydro-5,5-dimethyl- | [CAS]
1426309-31-0 | [Synonyms]
SGC agonist 1 6H-Pyrrolo[2,3-d]pyrimidin-6-one, 4-amino-2-[5-fluoro-1-[(2-fluorophenyl)methyl]-6-methyl-1H-pyrazolo[3,4-b]pyridin-3-yl]-5,7-dihydro-5,5-dimethyl- | [Molecular Formula]
C22H19F2N7O | [MOL File]
1426309-31-0.mol | [Molecular Weight]
435.43 |
| Hazard Information | Back Directory | [Uses]
SGC agonist 1 is a potent agonist of soluble guanylate cyclase (SGC). SGC agonist 1 improves solubility combined with high cell permeability. SGC agonist 1 has the potential for the research of cardiovascular disease (extracted from patent WO2016030354A1, compound 18A)[1]. | [References]
[1] Alexandros Vakalopoulos, et al. Amino-substituted annulated pyrimidines and use thereof. Patent WO2016030354A1. |
|
| Company Name: |
Biorbyt Ltd.
|
| Tel: |
+44 (0)1223 859 353 |
| Website: |
http://www.biorbyt.com |
|